Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil and Losartan in Idiopathic Pulmonary Fibrosis
NCT00981747Phase 3Terminated
- Start
- Sep 2009
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ASP-001 and losartan in idiopathic pulmonary fibrosis (IPF). Started Sep 2009; status: terminated.
02
Drugs
ASP-001losartan
03
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on NCT00981747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00981747.